Welcome!
DBS Group Research
Broker's Calls
Analysts maintain 'buy' on CapitaLand Ascott Trust with lower TPs following slower growth
Receding reopening tailwinds are likely to result in slower growth for subsequent quarters.
November 01, 2023
Broker's Calls
Analysts mixed on UOB’s outlook after 3QFY2023 results
Analysts' target prices range from $29.70 to $35.90.
November 01, 2023
Broker's Calls
DBS upgrades OUE Commercial REIT to ‘buy’ as hospitality sector recovers ahead of expectations
DBS's target price of 35 cents on the REIT implies a target yield of 6% and 0.6x P/NAV.
November 01, 2023
Broker's Calls
Analysts mixed on MPACT; CGS-CIMB upgrades to 'add' with lower TP; Maybank downgrades to 'hold' with lower TP
All analysts note that the REIT’s Singapore assets continue to outperform, but decline in DPU was due to higher costs and forex.
October 31, 2023
Broker's Calls
Wilmar showing signs of mending profitability, analysts keep 'buy'
Wilmar’s FY2024 earnings could recover from the low level expected this year, mainly on the trend of improving sales volume.
October 31, 2023
Broker's Calls
Analysts trim estimates and TPs on FCT after 2HFY2023 and FY2023 results
The analysts' target prices range from $2.12 to $2.60.
October 30, 2023
Broker's Calls
DBS, UOBKH and CGS-CIMB analysts keep 'buy' and 'add' calls on MINT, while Citi and Maybank keep 'neutral' and 'hold'
This follows the REIT’s 2QFY2023/2024 ended Sept 30 results with “healthy gearing” and robust rental reversions, say analysts.
October 30, 2023
Broker's Calls
DBS analysts lower TP for CLINT despite strong 3QFY2023 results, due to depreciation of INR-SGD
Analysts Dale Lai and Derek Tan have maintained their “buy” call, but lowered their target price to $1.35.
October 27, 2023
Broker's Calls
CICT garners mixed results from analysts following 3QFY2023 update; RHB upgrades to ‘buy’
CapitaLand Integrate Commercial Trust has garnered mixed results from analysts following its Q3FY2023 update.
October 27, 2023
Broker's Calls
Brokers' Digest: Suntec REIT, Tiong Woon, MLT, Keppel DC REIT, ComfortDelGro, Hyphens Pharma, Frencken
See what the analysts have to say this week.
October 27, 2023